SIM
NXTM

Sentry Investment Management’s NxStage Medical Inc. NXTM Stock Holding History

Sentry Investment Management’s Portfolio NXTM Stock Details NXTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-144,030
Closed -$2.27M – 539
2015
Q3 		$2.27M Buy
144,030
+32,488
+29% +$521K 0.11% 151
2015
Q2 		$1.59M Buy
+111,542
New +$1.89M 0.07% 214

Other funds holding NXTM

GGHC
Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RIM
RS Investment Management San Francisco, California $9.73B AUM 3.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
OIM
Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
CAM
Cortina Asset Management Milwaukee, Wisconsin $1.62B AUM 15.44% 1-Year Est. Return
TA
Tamarack Advisers Carlsbad, California $2.12M AUM 58.09% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return

Sentry Investment Management's NXTM Position: Q4 2015 in Review

Sentry Investment Management sold out of NxStage Medical Inc. (NXTM) in Q4 2015, closing a stake of 144,030 shares — an estimated $2.27M sold.

Sentry Investment Management first reported a position in NXTM in Q2 2015 and held it in 2 quarters. The position peaked at $2.27M in Q3 2015. 140 funds tracked by Wall St. Rank hold NXTM as of Q4 2015.

  • Sentry Investment Management reported no remaining NxStage Medical Inc. position as of Q4 2015 after selling out during the quarter.
  • Sentry Investment Management sold 144,030 NxStage Medical Inc. shares in Q4 2015, an estimated $2.27M.
  • Sentry Investment Management first reported a position in NxStage Medical Inc. in Q2 2015 and held it in 2 quarters.
  • Sentry Investment Management's NxStage Medical Inc. position peaked at $2.27M in Q3 2015.
  • 140 funds tracked by Wall St. Rank held NxStage Medical Inc. as of Q4 2015.

Based on Sentry Investment Management's 13F filing for Q4 2015, filed 20 Jan 2016.